Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm: Methodology and applications.
Journal
Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780
Informations de publication
Date de publication:
29 Dec 2022
29 Dec 2022
Historique:
entrez:
29
12
2022
pubmed:
30
12
2022
medline:
31
12
2022
Statut:
epublish
Résumé
The existing World Health Organization (WHO) pneumonia case management guidelines rely on clinical symptoms and signs for identifying, classifying, and treating pneumonia in children up to 5 years old. We aimed to collate an individual patient-level data set from large, high-quality pre-existing studies on pneumonia in children to identify a set of signs and symptoms with greater validity in the diagnosis, prognosis, and possible treatment of childhood pneumonia for the improvement of current pneumonia case management guidelines. Using data from a published systematic review and expert knowledge, we identified studies meeting our eligibility criteria and invited investigators to share individual-level patient data. We collected data on demographic information, general medical history, and current illness episode, including history, clinical presentation, chest radiograph findings when available, treatment, and outcome. Data were gathered separately from hospital-based and community-based cases. We performed a narrative synthesis to describe the final data set. Forty-one separate data sets were included in the Pneumonia Research Partnership to Assess WHO Recommendations (PREPARE) database, 26 of which were hospital-based and 15 were community-based. The PREPARE database includes 285 839 children with pneumonia (244 323 in the hospital and 41 516 in the community), with detailed descriptions of clinical presentation, clinical progression, and outcome. Of 9185 pneumonia-related deaths, 6836 (74%) occurred in children <1 year of age and 1317 (14%) in children aged 1-2 years. Of the 285 839 episodes, 280 998 occurred in children 0-59 months old, of which 129 584 (46%) were 2-11 months of age and 152 730 (54%) were males. This data set could identify an improved specific, sensitive set of criteria for diagnosing clinical pneumonia and help identify sick children in need of referral to a higher level of care or a change of therapy. Field studies could be designed based on insights from PREPARE analyses to validate a potential revised pneumonia algorithm. The PREPARE methodology can also act as a model for disease database assembly.
Sections du résumé
Background
UNASSIGNED
The existing World Health Organization (WHO) pneumonia case management guidelines rely on clinical symptoms and signs for identifying, classifying, and treating pneumonia in children up to 5 years old. We aimed to collate an individual patient-level data set from large, high-quality pre-existing studies on pneumonia in children to identify a set of signs and symptoms with greater validity in the diagnosis, prognosis, and possible treatment of childhood pneumonia for the improvement of current pneumonia case management guidelines.
Methods
UNASSIGNED
Using data from a published systematic review and expert knowledge, we identified studies meeting our eligibility criteria and invited investigators to share individual-level patient data. We collected data on demographic information, general medical history, and current illness episode, including history, clinical presentation, chest radiograph findings when available, treatment, and outcome. Data were gathered separately from hospital-based and community-based cases. We performed a narrative synthesis to describe the final data set.
Results
UNASSIGNED
Forty-one separate data sets were included in the Pneumonia Research Partnership to Assess WHO Recommendations (PREPARE) database, 26 of which were hospital-based and 15 were community-based. The PREPARE database includes 285 839 children with pneumonia (244 323 in the hospital and 41 516 in the community), with detailed descriptions of clinical presentation, clinical progression, and outcome. Of 9185 pneumonia-related deaths, 6836 (74%) occurred in children <1 year of age and 1317 (14%) in children aged 1-2 years. Of the 285 839 episodes, 280 998 occurred in children 0-59 months old, of which 129 584 (46%) were 2-11 months of age and 152 730 (54%) were males.
Conclusions
UNASSIGNED
This data set could identify an improved specific, sensitive set of criteria for diagnosing clinical pneumonia and help identify sick children in need of referral to a higher level of care or a change of therapy. Field studies could be designed based on insights from PREPARE analyses to validate a potential revised pneumonia algorithm. The PREPARE methodology can also act as a model for disease database assembly.
Identifiants
pubmed: 36579417
doi: 10.7189/jogh.12.04075
pmc: PMC9798037
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
04075Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
Copyright © 2022 by the Journal of Global Health. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and declare the following activities and relationships: YBN is staff member of the World Health Organization.
Références
Pediatr Pulmonol. 2020 Jun;55 Suppl 1:S37-S50
pubmed: 32074408
J Glob Health. 2021 Oct 09;11:04062
pubmed: 34737862
Lancet. 2013 Apr 20;381(9875):1405-1416
pubmed: 23582727
PLoS One. 2018 Feb 22;13(2):e0193557
pubmed: 29470524
Lancet. 2022 May 28;399(10340):2047-2064
pubmed: 35598608
Lancet Infect Dis. 2020 Jan;20(1):60-79
pubmed: 31678026
Lancet Respir Med. 2019 Dec;7(12):1068-1083
pubmed: 31591066
Lancet. 2015 Jan 31;385(9966):430-40
pubmed: 25280870
Lancet. 2018 Jul 14;392(10142):145-159
pubmed: 30025808
Acute Med. 2019;18(3):141-143
pubmed: 31536050
Acta Trop. 2004 Apr;90(2):211-4
pubmed: 15177148
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
Arch Dis Child. 2015 Feb;100 Suppl 1:S23-8
pubmed: 25613963
Lancet. 2019 Aug 31;394(10200):757-779
pubmed: 31257127
PLoS Med. 2020 Oct 23;17(10):e1003300
pubmed: 33095763
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Arch Dis Child. 1993 Apr;68(4):492-5
pubmed: 8503674
PLoS One. 2010 Aug 06;5(8):e11989
pubmed: 20700510
JAMA. 2017 Aug 01;318(5):462-471
pubmed: 28763554
BMJ Glob Health. 2020 Aug;5(8):
pubmed: 32792409
Lancet. 2013 Apr 20;381(9875):1380-1390
pubmed: 23369797
J Emerg Med. 2013 Nov;45(5):752-60
pubmed: 23937809
PLoS One. 2015 Sep 15;10(9):e0136166
pubmed: 26372640
BMJ Glob Health. 2022 Apr;7(4):
pubmed: 35428680
Lancet Infect Dis. 2015 Apr;15(4):439-50
pubmed: 25769269
Nature. 2015 Dec 3;528(7580):S53-9
pubmed: 26633766
PLoS One. 2019 Jun 20;14(6):e0214583
pubmed: 31220085
PLoS One. 2016 Jan 15;11(1):e0147560
pubmed: 26771879
Trans R Soc Trop Med Hyg. 1993 Nov-Dec;87(6):662-5
pubmed: 8296367